Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01328665
Other study ID # SCUIRB03282011-1
Secondary ID
Status Completed
Phase N/A
First received March 30, 2011
Last updated May 17, 2013
Start date April 2011
Est. completion date June 2012

Study information

Verified date May 2013
Source Santa Clara University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

This project evaluates the effectiveness of an intervention sought to reduce the physical effects of stress related to those issues that individuals cannot successfully communicate with anyone about. To do this, the investigators will be implementing a writing intervention over the course of the 6-week study. The investigators will be asking all participants to complete questionnaires over the course of the study period. The investigators are also asking participants to provide a small blood sample (from a fingerstick procedure) at two times during the study as well as saliva samples during that same time. The primary research question asks if this intervention procedure is effective. The investigators are evaluating total cholesterol, high sensitivity c-reactive protein, and cortisol.


Recruitment information / eligibility

Status Completed
Enrollment 44
Est. completion date June 2012
Est. primary completion date June 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- 110 pounds in weight

- Ability to fast for 8 hours prior to laboratory visit

- Staff member at Santa Clara University

- Certain level of inclusionary pretest stress measure

Exclusion Criteria:

- Hepatitis

- Endocrine Disease

- Kidney or Liver Disease

- Cancer (in any form)

- Cushing's disorder

- Rheumatological disorders

- Respiratory Disorders

- Diabetes

- High blood pressure

- Low blood pressure

- Heart or cardiovascular problems

- Chemotherapy

- Current use of alpha or beta blockers, steroids, or hormone replacements

- Pregnant and/or breastfeeding mothers

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
Expressive Writing
Writing intervention for cognitive appraisal of stressor.

Locations

Country Name City State
United States Santa Clara University, Health Center Santa Clara California

Sponsors (1)

Lead Sponsor Collaborator
Santa Clara University

Country where clinical trial is conducted

United States, 

References & Publications (1)

Floyd, K., Boren, J. P., Hannawa, A. F., Hesse, C., McEwan, B., & Veksler, A. E. (2009). Kissing in marital and cohabiting relationships: Effects on blood lipids, stress, and relationship satisfaction. Western Journal of Communication, 73(2), 113 - 133. doi: 10.1080/10570310902856071

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Lipids from baseline Lipid panel includes total cholesterol, High-density lipoproteins, low-density lipoprotein, and triglycerides. Week 1 and Week 6 No
Primary Change in high-sensitivity c-Reactive Protein from baseline Week 1 and Week 6 No
Primary Change in Cortisol Awakening Response from Baseline Measurement of Salivary Cortisol (hydrocortisone, compound-F) as a maximum difference between awakening and 30 minutes after awakening. Week 1 and Week 6 No
Secondary Change in Perceived Global Stress over time Psychological measure of stress Week 1, Week 3, Week 6 No
Secondary Change in Organizational Stress over time Psychological measure of stress as a function of organizational involvement. Week 1, Week 3, Week 6 No
Secondary Change in Perception of Communication Restriction of Stressor over time Restrictedness of a communicative stressor Week 1, Week 3, Week 6 No
See also
  Status Clinical Trial Phase
Completed NCT05322161 - Yoga in the NICU for Parents Study N/A
Completed NCT02680730 - The Listening Project at the ADD Centre and Biofeedback Institute of Toronto N/A
Completed NCT03311529 - Effectiveness and Underlying Mechanisms of Applied Relaxation as Indicated Preventive Intervention N/A
Completed NCT03056872 - Stress Reactivity as a Determinant in Co-occurring Alcohol Use and Anxiety Disorder: Diagnosis and Alcohol Use Outcomes
Terminated NCT04491071 - Stress Induced by the COVID-19 Pandemic and Nonconfinement: Study of Anxiety Factors and Potential Effects on Immunity.
Withdrawn NCT03271086 - Relaxation Breathing Training for Children N/A
Completed NCT02398422 - The Listening Project at Reiss-Davis/Vista Del Mar Child and Family Services N/A
Completed NCT02064257 - The Listening Project: Tuning Into Change N/A
Recruiting NCT05784259 - Development of Transdiagnostic Single-session Treatment N/A
Completed NCT03934658 - Remote Study of NightWare for PTSD With Nightmares N/A
Recruiting NCT05712057 - Neurostimulation Versus Therapy for Problems With Emotions N/A
Completed NCT05573009 - The Effect of Stress Reduction Program on Pregnancy Process and Mental Health in High Risk Pregnant Women N/A
Withdrawn NCT03258476 - Guanfacine Extended Release and Mindfulness Skills Therapy Phase 4
Enrolling by invitation NCT04396600 - The Professional Peer Resilience Initiative
Completed NCT03550833 - Impact of Life Events and Psychological Stress in Rheumatoid Arthritis Set-up : Case-control Study Within a Multifactorial and Integrative Psychological Model
Recruiting NCT05415163 - Vascular Photobiomodulation on Sleep Qualityand Stress N/A
Not yet recruiting NCT06235177 - Psychoneuromentalism Disorder: A Medical Condition That Affects People With Psychological Impairments From Health Issues Early Phase 1
Completed NCT04584021 - Use of Wearable Devices to Assess the Impact of Stress in Workers' Life Quality
Completed NCT04083300 - Cancer, Physical Activity and Quality of Life- a Longterm Follow up
Terminated NCT05260541 - A Clinical Trial of PRAX-114 in Participants With Post-Traumatic Stress Disorder Phase 2